Combined effects of valproate and naringin on kidney antioxidative markers and serum parameters of kidney function in C57BL6 mice.

Autor: Jutrić D; 1University of Zagreb Faculty of Science, Zagreb, Croatia.; 2Regionshospitalet Gødstrup, Herning, Denmark., Đikić D; 1University of Zagreb Faculty of Science, Zagreb, Croatia., Boroš A; 1University of Zagreb Faculty of Science, Zagreb, Croatia.; 3Czech Academy of Sciences, Institute of Physiology, Prague, Czechia., Odeh D; 1University of Zagreb Faculty of Science, Zagreb, Croatia., Gračan R; 1University of Zagreb Faculty of Science, Zagreb, Croatia., Beletić A; 4Genos Ltd., Glycoscience Research Laboratory, Zagreb, Croatia., Jurčević IL; 5University of Zagreb Faculty of Food Technology and Biotechnology, Zagreb, Croatia.
Jazyk: angličtina
Zdroj: Arhiv za higijenu rada i toksikologiju [Arh Hig Rada Toksikol] 2023 Sep 30; Vol. 74 (3), pp. 218-223. Date of Electronic Publication: 2023 Sep 30 (Print Publication: 2023).
DOI: 10.2478/aiht-2023-74-3764
Abstrakt: Valproate is known to disturb the kidney function, and high doses or prolonged intake may cause serum ion imbalance, kidney tubular acidosis, proteinuria, hyperuricosuria, polyuria, polydipsia, and dehydration. The aim of this in vivo study was to see whether naringin would counter the adverse effects of high-dose valproate in C57Bl/6 mice and to which extent. As expected, valproate (150 mg/kg bw a day for 10 days) caused serum hyperkalaemia, more in male than female mice. Naringin reversed (25 mg/kg bw a day for 10 days) the hyperkalaemia and activated antioxidative defence mechanisms (mainly catalase and glutathione), again more efficiently in females. In males naringin combined with valproate was not as effective and even showed some prooxidative effects.
(© 2023 David Jutrić et al., published by Sciendo.)
Databáze: MEDLINE